Targeting of embryonic and postnatal autonomic and enteric neurons with a vasoactive intestinal peptide transgene

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1739-1748

  Waschek, James A ^a   Bravo, Dawn T ^a   Sena, Matthew ^a   Casillas, Robert ^a   Rodriguez, Williams ^a   Nguyen, Thinh ^a   Colburn, Steve ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholinergic; Embryo; Neonate; Promoter; Transgenic; Vasoactive intestinal peptide

Indexed keywords

BETA GALACTOSIDASE; MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; INTESTINE INNERVATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RESTRICTION MAPPING; RNA ANALYSIS; STOMACH INNERVATION; SYMPATHETIC NERVE CELL; TRANSGENE; TRANSGENIC MOUSE;

AGING; ANIMALS; ANIMALS, NEWBORN; BETA-GALACTOSIDASE; BRAIN; DIGESTIVE SYSTEM; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; NEURONS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RESTRICTION MAPPING; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032877450     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.731739.x     Document Type: Article

References (34)

1. Agoston D. A., Bravo D. T., and Waschek J. A. (1990) Expression of a chimeric VIP gene is targeted to the intestine in transgenic mice. J. Neurosci. Res. 27, 479-486.
2. Ang H.-L., Carter D. A., and Murphy D. (1993) Neuron-specific expression and physiological regulation of bovine vasopressin transgenes in mice. EMBO J. 12, 2397-2409.
3. Dussaillant M., Sarrieau A., Gozes I., Berod A., and Rostene W. (1992) Distribution of cells expressing vasoactive intestinal peptide/peptide histidine isoleucine-amide precursor messenger RNA in the rat brain. Neuroscience 50, 519-530.
4. Fink J., Montminy M. R., Tsukada T., Hoefler H., Specht L. A., Lechan R. M., Wolfe H., Mandel G. and Goodman R. H. (1986) In situ hybridization of somatostatin and VIP mRNA in the rat nervous system, in In Situ Hybridization in Brain (Uhl G., ed), pp. 181-191. Plenum Press, New York.
5. Furness J. B., Bornstein J. C., and Smith T. K. (1990) The normal structure of gastrointestinal innervation. J. Gastroenterol Hepatol. 1, 1-9.
6. Graber M. and Burgunder J. M. (1996) Ontogeny of vasoactive intestinal peptide gene expression in rat brain. Anat. Embryol. (Berl.) 194, 595-605.
7. Hahm S. H. and Eiden L. E. (1996) Tissue-specific expression of the vasoactive intestinal peptide gene requires both an upstream tissue specifier element and the 5′ proximal cyclic AMP-responsive element. J. Neurochem. 67, 1872-1881.
8. Hahm S. H. and Eiden L. E. (1998) Five discrete cis-active domains direct cell type-specific transcription of the vasoactive intestinal peptide (VIP) gene. J. Biol. Chem. 273, 17086-17094.
9. Hökfelt T., Schultzberg M., Lundberg J. M., Fuxe K., Mutt V., Fahrenkrug J., and Said S. I. (1982) Distribution of vasoactive intestinal polypeptide in the central and peripheral nervous systems as revealed by immunocytochemistry, in Vasoactive Intestinal Peptide (Said S., ed), pp. 65-90. Raven Press, New York.
10. Lamperti E. D., Rosen K. M., and Villa-Komaroff L. (1991) Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse. Brain Res. Mol. Brain Res. 9, 217-231.
11. Landis S. C. (1983) Development of cholinergic sympathetic neurons: evidence for transmitter plasticity in vivo. Fed. Proc. 42, 1633-1638.
12. Leblanc G. G., Trimmer B. A., and Landis S. C. (1987) Neuropeptide Y-like immunoreactivity in rat cranial parasympathetic neurons: coexistence with vasoactive intestinal peptide and choline acetyltransferase. Proc. Natl. Acad. Sci. USA 84, 3511-3515.
13. Lem J., Applebury M. L., Falk J. D., Flannery J. G., and Simon M. I. (1991) Tissue-specific and developmental regulation of rod opsin chimeric genes in transgenic mice. Neuron 6, 201-210.
14. Lundberg J. M., Fahrenkrug J., Hökfelt T., Martling C. R., Larsson O., Tatemoto K., and Anggard A. (1984) Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides 5, 593-606.
15. Morales M. A., Holmberg K., Xu Z. Q., Cozzari C., Hartman B. K., Emson P., Goldstein M., Elfvin L. G., and Hökfelt T. (1995) Localization of choline acetyltransferase in rat peripheral sympathetic neurons and its coexistence with nitric oxide synthase and neuropeptides. Proc. Natl. Acad. Sci. USA 92, 11819-11823.
16. Murphy D., Bishop A., Rindi G., Murphy M. N., Stamp G. W. H., Hanson J., Polak J. M., and Hogan B. (1987) Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1. Am. J. Pathol. 129, 552-556.
17. Russo A. F., Crenshaw E. B. III, Lira S. A., Simmons D. M., Swanson L. W., and Rosenfeld M. G. (1988) Neuronal expression of chimeric genes in transgenic mice. Neuron 1, 311-320.
18. Schutz B., Schafer M. K., Eiden L. E., and Weihe E. (1998) VIP and NPY expression during differentiation of cholinergic and noradrenergic sympathetic neurons. Ann. NY Acad. Sci. 865, 537-541.
19. Sena M., Agoston D., and Waschek J. (1994) High conservation of upstream regulatory sequence on the mouse and human vasoactive intestinal peptide genes. DNA Seq. 5, 25-29.
20. Sun Y. and Zigmond R. E. (1996) Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal peptide mRNA and the decreases in neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after axotomy. J. Neurochem. 67, 1751-1760.
21. Symes A. J., Corpus L., and Fink J. S. (1995) Differences in nuclear signaling by leukemia inhibitory factor and interferon-γ: the role of STAT proteins in regulating vasoactive intestinal peptide gene expression. J. Neurochem. 65, 1926-1933.
22. Tolentino P. J., Dikkes P., Tsuruda L., Ebert K., Fink J. S., Villa-Komaroff L., and Lamperti E. D. (1995) Quantitative analysis of the expression of a VIP transgene. Brain Res. Mol. Brain Res. 33, 47-60.
23. Tsien J. Z., Huerta P. T., and Tonegawa S. (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87, 1327-1338.
24. Tsukada T., Fink J. S., Mandel G., and Goodman R. H. (1987) Identification of a region in the human vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP. J. Biol. Chem. 262, 8743-8747.
25. Tsuruda L. M., Lamperti E. D., Lewis S. E., Tolentino P. J., Dikkes P., Villa-Komaroff L., Ebert K. M., and Fink J. S. (1996) Region-specific central nervous system expression and axotomy-induced regulation in sympathetic neurons of a VIP-beta-galactosidase fusion gene in transgenic mice. Brain Res. Mol. Brain Res. 42, 181-192.
26. Tyrrell S. and Landis S. C. (1994) The appearance of NPY and VIP in sympathetic neuroblasts and subsequent alterations in their expression. J. Neurosci. 14, 4529-4547.
27. Waschek J. A. (1994) Environmental and hormonal control of vasoactive intestinal peptide (VIP) gene expression and changes in pathological conditions, in Frontiers in Neurobiology, Vol. 1: Neuropeptide Gene Expression (Turner A. J., ed), pp. 107-132. Portland Press, London.
28. Waschek J. (1995) Transgenic targeting of neuroendocrine peptide genes in the hypothalamic-pituitary axis. Mol. Neurobiol. 10, 205-217.
29. Waschek J. A., Hsu C.-M., and Eiden L. E. (1988) Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5′-flanking sequence. Proc. Natl. Acad. Sci. USA 85, 9547-9551.
30. Waschek J. A., Krajniak K. G., Bravo D. T., and Agoston D. A. (1992) Regulation of human and mouse vasoactive intestinal peptide genes. Biomed. Res. 13 (Suppl. 2), 1-6.
31. Waschek J. A., Ellison J., Bravo D. T., and Hadley V. (1996) Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes. J. Neurochem. 66, 1762-1765.
32. Waschek J. A., Casillas R. A., Nguyen T. B., DiCicco-Bloom E. M., Carpenter E. M., and Rodriguez W. I. (1998) Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proc. Natl. Acad. Sci. USA 95, 9602-9607.
33. Yuh C. H., Bolouri H., and Davidson E. H. (1998) Genomic cis-regulatory logic: experimental and computational analysis of a sea urchin gene. Science 279, 1896-1902.
34. Zigmond R. E. (1997) LIF, NGF, and the cell body response to axotomy. Neuroscientist 3, 176-185.